英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
VPC 23019 |
VPC 23019 |
449173-19-7 |
詳細(xì)
|
MCC950 |
MCC950 |
210826-40-7 |
詳細(xì)
|
CID-49830258 |
ML240 |
1346527-98-7 |
詳細(xì)
|
Methanone, [4-(1,1-dimethylethyl)-1-piperidinyl][4-(hydroxydiphenylmethyl)-2H-1,2,3-triazol-2-yl]- |
化合物ML-211 |
2205032-89-7 |
詳細(xì)
|
2H-1-Benzopyran-2-one, 7-(1,1-dimethyloctyl)-5-hydroxy-3-[(2-hydroxyphenyl)methyl]- |
化合物PSB-SB-487 |
1399049-81-0 |
詳細(xì)
|
RBC10 |
RBC10 |
362503-73-9 |
詳細(xì)
|
GSK J1 |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氫-3H-3-苯并氮雜卓-3-基)-4-嘧啶基]-BETA-丙氨酸 |
1373422-53-7 |
詳細(xì)
|
PD089828 |
PD089828 |
179343-17-0 |
詳細(xì)
|
SGC707 |
N-6-異喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 |
1687736-54-4 |
詳細(xì)
|
CRANAD 28 |
CRANAD 28 |
1623747-97-6 |
詳細(xì)
|
ARN272 |
ARN272 |
488793-85-7 |
詳細(xì)
|
BPU-11 |
BPU-11 |
909664-41-1 |
詳細(xì)
|
CE3F4 |
143703-25-7 |
143703-25-7 |
詳細(xì)
|
GSK5182 |
CS-2620 |
877387-37-6 |
詳細(xì)
|
NIBR 0213 |
NIBR 0213 |
1233332-14-3 |
詳細(xì)
|
BDP5290 |
BDP5290 |
1817698-21-7 |
詳細(xì)
|
Kv2-IN-A1 |
化合物RY785 |
689297-68-5 |
詳細(xì)
|
AEM1 |
AEM1 |
1030123-90-0 |
詳細(xì)
|
7-Amino-4-chloro-3-propoxy-isochromen-1-one |
7-Amino-4-chloro-3-propoxy-isochromen-1-one |
126062-19-9 |
詳細(xì)
|
SGA 293 |
SGA360 |
680611-86-3 |
詳細(xì)
|
1,3-Benzenediol, 4-[1-(2-propenyl)-7-(trifluoromethyl)-1H-indazol-3-yl]- |
1,3-Benzenediol, 4-[1-(2-propenyl)-7-(trifluoromethyl)-1H-indazol-3-yl]- |
669764-18-5 |
詳細(xì)
|
Creatine riboside |
Creatine riboside |
1616693-92-5 |
詳細(xì)
|
BRD6688 |
BRD6688 |
1404562-17-9 |
詳細(xì)
|
PS 210 |
PS 210 |
1221962-86-2 |
詳細(xì)
|
GSK106 (hydrochloride) |
GSK106 (hydrochloride) |
1652591-82-6 |
詳細(xì)
|
N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine |
SR-3029 |
1454585-06-8 |
詳細(xì)
|
1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-butyl-6-(methylsulfonyl)- |
MSBN |
135980-66-4 |
詳細(xì)
|
ONO-8130 |
ONO-8130 |
459841-96-4 |
詳細(xì)
|
ML311 |
315698-17-0 |
315698-17-0 |
詳細(xì)
|
RO-5203648 |
RO-5203648 |
1043491-54-8 |
詳細(xì)
|
WBYNZQXAAWPAGR-UHFFFAOYSA-N |
CS-2866 |
1637300-25-4 |
詳細(xì)
|
4-(2-(5-(3,5-dimethylisoxazol-4-yl)-2-(4-propoxyphenethyl)-1H-benzo[d]imidazol-1-yl)ethyl)morpholine |
PF-CBP1 |
962928-21-7 |
詳細(xì)
|
TSPC |
TSPC |
882286-32-0 |
詳細(xì)
|
AS1842856 |
5-氨基-7-(環(huán)己基氨基)-1-乙基-6-氟-1,4-二氫-4-氧代-3-喹啉羧酸 |
836620-48-5 |
詳細(xì)
|
(S)-2,2-dimethyl-1-(5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)propan-1-one |
GSK963(S構(gòu)型) |
2049868-46-2 |
詳細(xì)
|
1-Propanone, 1-[(5R)-4,5-dihydro-5-phenyl-1H-pyrazol-1-yl]-2,2-dimethyl- |
1-Propanone, 1-[(5R)-4,5-dihydro-5-phenyl-1H-pyrazol-1-yl]-2,2-dimethyl- |
2049872-86-6 |
詳細(xì)
|
2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro- |
2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro- |
1481401-71-1 |
詳細(xì)
|
SRI-011381 SRI011381 N'-Cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl)-urea |
SRI011381 |
1629138-41-5 |
詳細(xì)
|
Benzoic acid,5-[2-[4-[2-(2,4-diamino-5-methylphenyl)diazenyl]phenyl]diazenyl]-2-hydroxy-,sodium salt (1:1) |
Benzoic acid,5-[2-[4-[2-(2,4-diamino-5-methylphenyl)diazenyl]phenyl]diazenyl]-2-hydroxy-,sodium salt (1:1) |
6300-44-3 |
詳細(xì)
|
ML198 |
化合物ML198 |
1380716-06-2 |
詳細(xì)
|
Epiblastin A |
Epiblastin A |
16470-02-3 |
詳細(xì)
|
FARAMPATOR |
CX691 |
211735-76-1 |
詳細(xì)
|
FIN56 |
FIN56 |
1083162-61-1 |
詳細(xì)
|
ML246 |
METARRESTIN |
1443414-10-5 |
詳細(xì)
|
4-Quinazolinamine, N-(5-methyl-1H-pyrazol-3-yl)-2-phenyl- |
N-(5-甲基-1H-吡唑-3-基)-2-苯基-4-喹唑啉胺 |
404828-14-4 |
詳細(xì)
|
pythiDC |
化合物PYTHIDC |
1821370-71-1 |
詳細(xì)
|
(S)-SHA 68 |
|
847555-75-3 |
詳細(xì)
|
NCGC607 |
NCGC607 |
1462267-07-7 |
詳細(xì)
|
2-(2-((4-bromophenyl)amino)-2-oxoethoxy)-N-(2-(methyl(phenyl)amino)-2-oxoethyl)benzamide |
2-(2-((4-bromophenyl)amino)-2-oxoethoxy)-N-(2-(methyl(phenyl)amino)-2-oxoethyl)benzamide |
1462267-08-8 |
詳細(xì)
|
BMS 986187 |
BMS 986187 |
684238-37-7 |
詳細(xì)
|
BMS 986188 |
BMS 986188 |
1776115-10-6 |
詳細(xì)
|
APS-2-79 |
2002381-25-9 |
2002381-25-9 |
詳細(xì)
|
TTK21 |
TTK21 |
709676-56-2 |
詳細(xì)
|
ML-226 |
ML-226 |
2055172-43-3 |
詳細(xì)
|
MN58b |
化合物MN58B |
203192-01-2 |
詳細(xì)
|
SGC2085 |
SGC2085.HCL |
1821908-49-9 |
詳細(xì)
|
6-Chloro-N4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine |
6-氯-N4-[3,5-二氟-4-[(3-甲基-1H-吡咯并[2,3-B]吡啶-4-基)氧]苯基]-2,4-嘧啶二胺 |
867017-68-3 |
詳細(xì)
|
Shield-1 |
化合物SHIELD-1 |
914805-33-7 |
詳細(xì)
|
PF-794 |
PF-794 |
2056111-45-4 |
詳細(xì)
|
NCGC00262650 |
NCGC00262650 |
344359-25-7 |
詳細(xì)
|
ERDRP-0519 |
ERDRP-0519 |
1374006-96-8 |
詳細(xì)
|
WWL229 |
WWL229 |
1338575-28-2 |
詳細(xì)
|
AA41612 |
化合物AA41612 |
433690-62-1 |
詳細(xì)
|
2(1H)-Pyridinone, 3-[(2-chlorophenyl)thio]-5,6-dihydro-4-hydroxy-6-[4-(4-morpholinyl)phenyl]-6-(3-thienyl)- |
化合物 T27421 |
1809794-70-4 |
詳細(xì)
|
GNE-140 (racemate) |
GNE140 racemate |
1802977-61-2 |
詳細(xì)
|
4-Piperidinecarboxylic acid, 1-[[4-(4-hydroxy-1-butyn-1-yl)phenyl]methyl]-4-[[3-(trifluoromethyl)phenyl]methyl]-, ethyl ester |
化合物SOPORIDINE |
1060376-43-3 |
詳細(xì)
|
2-CARBOXY PHENYLSULFAMIDE |
鄰磺酰胺苯甲酸 |
632-24-6 |
詳細(xì)
|
IMIDACLOPRID IMPURITY 1 |
吡蟲啉雜質(zhì)1 |
105828-41-9 |
詳細(xì)
|
1-[(6-chloropyridin-3-yl)Methyl]iMidazolidin-2-one |
甲醇中吡蟲啉-尿素溶液,100ΜG/ML |
120868-66-8 |
詳細(xì)
|
2-propyl-1,2,3,6-tetrahydro-pyridine |
|
54565-96-3 |
詳細(xì)
|
pyrimorph |
丁吡嗎啉 |
868390-90-3 |
詳細(xì)
|
GSK840 |
GSK840 |
2361146-30-5 |
詳細(xì)
|
GSK199 (hydrochloride) |
GSK199;GSK 199 |
1549811-53-1 |
詳細(xì)
|
N-(4-chlorophenyl)-2-(3,5-diMethyl-1H-pyrazol-1-yl)-9-Methyl-9H-purin-6-aMine |
N-(4-氯苯基)-2-(3,5-二甲基-1H-吡唑-1-基)-9-甲基-9H-嘌呤-6-胺 |
1063331-94-1 |
詳細(xì)
|
Takeda103A |
Takeda103A |
865609-72-9 |
詳細(xì)
|
2-Cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide |
2-氰基-3-[5-(2,5-二氯苯基)-2-呋喃基]-N-5-喹啉基-2-丙烯酰胺 |
304896-28-4 |
詳細(xì)
|
Benzo[b]thiophene-6-ol, 2-(4-hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenyl]- |
Benzo[b]thiophene-6-ol, 2-(4-hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenyl]- |
216570-81-9 |
詳細(xì)
|
Squarunkin A |
化合物SQUARUNKINA |
2101958-02-3 |
詳細(xì)
|
1-Piperidinepropanamide, N-[1,2,3,9-tetrahydro-9-oxo-3-(phenylmethylene)pyrrolo[2,1-b]quinazolin-6-yl]- |
1-Piperidinepropanamide, N-[1,2,3,9-tetrahydro-9-oxo-3-(phenylmethylene)pyrrolo[2,1-b]quinazolin-6-yl]- |
90263-34-6 |
詳細(xì)
|
CIL56 |
2,7-雙(哌啶-1-基磺?;?-9H-芴-9-酮肟 |
300802-28-2 |
詳細(xì)
|
ALE-0540
(ALE0540) |
ALE-0540 |
234779-34-1 |
詳細(xì)
|
Benzeneacetic acid, 4-[2-(cyclopentylamino)-1-[(2,3-dihydro-1H-inden-5-yl)[(1,5-diphenyl-1H-pyrazol-3-yl)carbonyl]amino]-2-oxoethyl]- |
|
2247439-36-5 |
詳細(xì)
|
GSK484 |
CS-2265 |
1652591-81-5 |
詳細(xì)
|
CLK inhibitor T3
(T3) |
CLK inhibitor T3
(T3) |
2109805-56-1 |
詳細(xì)
|
A-485 |
1889279-16-6 |
1889279-16-6 |
詳細(xì)
|
AH3960 |
化合物AH-3960 |
862907-48-0 |
詳細(xì)
|
GSK864 |
1816331-66-4 |
1816331-66-4 |
詳細(xì)
|
1H-Indazole-3-carboxamide, N-[1-(3,4-difluorophenyl)ethyl]- |
1H-Indazole-3-carboxamide, N-[1-(3,4-difluorophenyl)ethyl]- |
877969-69-2 |
詳細(xì)
|
BAY-293 |
(R)-6,7-二甲氧基-2-甲基-N-(1-(4-(2-((甲基氨基)甲基)苯基)噻吩-2-基)乙基)喹唑啉-4-胺 |
2244904-70-7 |
詳細(xì)
|
Gboxin |
Gboxin |
2101315-36-8 |
詳細(xì)
|
RU.521 |
RU320521 |
2262452-06-0 |
詳細(xì)
|
SC 57461A |
N -甲基- N -[3 - [4 - (苯甲基)苯氧基]丙基Β-丙氨酸鹽酸鹽 |
423169-68-0 |
詳細(xì)
|
LOC-14 |
2-((4-(環(huán)丙烷羰基)哌嗪-1-基)甲基)苯并[D]異噻唑-3(2H)-酮 |
877963-94-5 |
詳細(xì)
|
5-{2',6'-dihydroxy-[1,1'-biphenyl]-4-yl}-1H-indole-3-carbonitrile |
5-{2',6'-dihydroxy-[1,1'-biphenyl]-4-yl}-1H-indole-3-carbonitrile |
1179347-65-9 |
詳細(xì)
|
N-[2-(4-methoxybenzoyl)-1-benzofuran-3-yl]acetamide |
化合物NPD8733 |
696655-62-6 |
詳細(xì)
|
ICA-105574 |
化合物ICA-105574 |
316146-57-3 |
詳細(xì)
|
Adenosine, N-(3-hydroxyphenyl)-, 2',3',5'-triacetate |
化合物IMM-H007 |
1221412-23-2 |
詳細(xì)
|
OSMI-1 |
OSMI-1 |
1681056-61-0 |
詳細(xì)
|
SR31527 |
SR31527 |
311814-78-5 |
詳細(xì)
|
Autogramin-1 |
化合物AUTOGRAMIN-1 |
2375541-73-2 |
詳細(xì)
|